TBTC is a selective retinoid X receptor α agonist. It acts by improving behaviorally bioavailable deficit in Alzheimer's disease model mice. References: Vjecha MJ, Tiberi S, Zumla A. Accelerating the development of therapeutic strategies for drug-resistant tuberculosis. Nat Rev Drug Discov. 2018 Mar 23. doi: 10.1038/nrd.2018.28. [Epub ahead of print] PubMed PMID: 29567994.

纯度：≥98%

CAS：213192-26-8